Medical Devices Startups
6,551 companies tagged Medical Devices, with their investors and founders.
Vita Imaging is a medical technology company developing AURAβ’, a non-invasive imaging and spectroscopy device that uses Raman spectroscopy and machine learning to distinguish benign from malignant skin lesions in real time for point-of-care cancer screening. It builds physician decision-support diagnostic systems aimed at healthcare providers for early cancer detection.
0 investors
Vitanova Biomedical develops cancer treatments based on a proprietary light-activated intracellular acidosis (LAIA) therapy that uses upconverting nanoparticles and deep-penetrating light to induce cancer cell death. The company operates in the biomedical and oncology therapeutics space.
0 investors
Vivamed develops a minimally invasive neuromodulation treatment for obstructive sleep apnea. The company operates in the medical device and sleep health space.
0 investors
VivortΓ© develops and commercializes orthopedic medical devices focused on maintaining or improving bone strength and speeding the healing process for patients, surgeons, hospitals, and payers. It manufactures its products in cleanroom environments and processes biologic tissue under regulated quality standards.
0 investors
Volition develops Nu.Q epigenetics-based blood tests that detect nucleosome changes associated with cancer, sepsis, and other diseases in both humans and animals. Its products include diagnostic assays for NETosis detection, research-use assays, and a canine cancer blood test.
0 investors
Voom is a medical device company that develops products for minimally invasive foot and ankle surgeries, with a focus on bunion procedures performed by surgeons. The company emphasizes patient-centered care and surgical innovation through specialized technology and surgeon training.
0 investors
Voximetry conducts PHS-funded research activities, including basic and applied research and product development related to public health. This page is the company's financial conflict of interest (FCOI) policy rather than a product description.
0 investors
Voyager Biomedical develops VenaSure, an implanted porous titanium device that creates a palpable access window to guide reliable cannulation of AV fistulas for hemodialysis patients. The device is intended for use in dialysis centers and home dialysis to reduce needle-related vein damage during vascular access.
0 investors
Vyriad is a clinical-stage biotechnology company developing oncolytic virus-based therapies for cancer treatment. It works on engineering viral cancer immunotherapies and GMP virus manufacturing, and has pharma partnerships with companies including Novartis, Regeneron, and Merck KGaA.
0 investors
Walden Medical is a medical device incubator that works with physicians and inventors to bring custom medical devices to market, offering an alternative funding and development model to venture capital or private equity. Its products include the RELIEF Stent, a ureteral stent designed to reduce stent-related pain, urine reflux, and bladder spasms.
0 investors
Walela develops a fetal sensor that provides objective data on a baby's health during labor, helping obstetricians decide whether a C-section is necessary with greater confidence and less liability. The company targets healthcare institutions and clinicians in the prenatal and childbirth monitoring space.
0 investors
Wavefront Dynamics is a medical device company that develops diagnostic and lens design systems for vision care, built on Shack-Hartmann wavefront sensor technology. Its WaveDΘ³n Vision Analyzer captures thousands of data points across the pupil to help clinicians measure and treat highly aberrated eyes.
0 investors
Wavegate develops the Ellipseβ’ platform, an implantable bioadaptive electroceutical system that combines multi-modal physiologic sensing (optical reflectometry, evoked potentials, hemodynamics, ECG, and motion) with AI-based state estimation and adaptive control to deliver closed-loop neuromodulation therapy, starting with spinal cord stimulation for chronic pain. The company targets clinicians and researchers in neuromodulation, with all programs currently investigational and not FDA-approved.
0 investors
Waypoint Orthopedics develops GPS (Guided Pedicle System), a vertebral fixation device that gives spine surgeons real-time guidance to improve accuracy and reduce radiation exposure during open and minimally invasive spine surgery. The FDA-cleared system is aimed at spine surgeons, surgical staff, and patients in the medical device/orthopedics field.
0 investors
West Lakes Surgery Center is an outpatient surgical facility offering comprehensive surgical services across multiple specialties in a patient-focused environment. Founded as a joint venture between Mercy Medical Center-Des Moines and area surgeons, it operates with seven operating rooms and specialized recovery facilities.
0 investors
Westpoint Optical offers Nuance Audio, a line of hearing glasses that amplify speech in noisy environments using directional microphone technology and open-ear speakers. The product targets individuals seeking an alternative to traditional hearing aids.
0 investors
WindMIL Therapeutics is a clinical-stage biotechnology company developing cell-based immuno-oncology therapies using marrow-infiltrating lymphocytes (MILs), T cells extracted from a cancer patient's bone marrow that are activated and expanded before being returned to the patient. The company has exclusively licensed the underlying patents and know-how for MILs therapy from Johns Hopkins University.
0 investors
XCR Diagnostics develops portable molecular diagnostic systems for rapid nucleic acid testing at the point of care. The Pyramid system delivers lab-quality results in approximately 7 minutes for infectious disease detection in hospitals, clinics, emergency rooms, and resource-limited settings.
0 investors
XDemics develops cell culture and biomanufacturing technologies for generating mammalian cells at high densities for advanced therapy production. The company's HDCR platform and related products enable researchers and GMP facilities to produce T cell, stem cell, and viral-based therapies with improved quality and consistency.
0 investors
Xenetic Biosciences is a biopharmaceutical company developing immuno-oncology technologies for hard-to-treat cancers. Its DNase platform targets neutrophil extracellular traps (NETs) to improve existing treatments, with a systemic DNase program being advanced into the clinic as an adjunctive therapy for pancreatic carcinoma and other solid tumors.
0 investors
Xenocor is a company that has completed a Series A funding round; the investors page provides an investor deck but does not describe the company's product or business.
0 investors
XenoTherapeutics develops regenerative medicine therapies derived from genetically engineered pigs as a living donor source, aiming to replace human cadaver tissue. Its first product, realSKIN, is a living skin transplant intended to support healing after severe injury.
0 investors
Zywie provides software solutions for cardiology and cardiac care, with a focus on arrhythmia management and electrophysiology. The company develops enterprise applications serving healthcare providers and cardiac specialists.
0 investors